Madrigal Pharmaceuticals Inc. trailing returns
Madrigal Pharmaceuticals Inc.'s 10-year return is +44.4% a year (CAGR) (+3838.5% cumulative). How Madrigal Pharmaceuticals Inc. (MDGL) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through October 2, 2026 — cumulative and annualized, with dividends on or off.
Trailing returns by period#
To 2026-10-02. Annualized (CAGR) for windows of a year or more.
| Period | Path | Annualized | Cumulative |
|---|---|---|---|
| 1 day | — | -0.1% | |
| 5 days | — | -3.3% | |
| 1 month | — | -8.7% | |
| YTD | — | -14.2% | |
| 1 year | +11.1% | +11.1% | |
| 5 years | +44.1% | +520.8% | |
| 10 years | +44.4% | +3838.5% | |
| Since inception (2007) | +2.3% | +57.0% |
Growth of MDGL
Actual index level (solid); dashed lines are each window's constant-rate path from start to today.
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-02). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Total return reinvests dividends (from MDGL's split- and dividend-adjusted closes); price return excludes them. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Madrigal Pharmaceuticals Inc.'s 10-year return?
- Over the last 10 years, Madrigal Pharmaceuticals Inc. (MDGL) returned about +44.4% a year annualized (+3838.5% cumulative total return).
- What is Madrigal Pharmaceuticals Inc.'s return since inception?
- Since 2007, Madrigal Pharmaceuticals Inc. (MDGL) has compounded at about +2.3% a year — +57.0% in total.